Meanwhile, urine C–C motif chemokine ligand 14 (CCL14) was recently reported to have a good even excellent performance in predicting persistent KDIGO stage 3 AKI, with areas under the receiver operating characteristic curves (AUCs) from 0.81 to 0.93 [12–14]. This evidence concerns the gene CCL14 and acute kidney injury.